Maximilian Einsiedler

10PUBLICATIONS
45CO-AUTHORS
Neurology and neuromuscular diseasesEconomic models and forecastingPsychosocial aspects of childbirth and perinatal mental healthRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
Comorbidities in multiple sclerosis: acquired hepatocerebral degeneration mimicking disease progression.

|Apr 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

|Feb 19, 2026
Are neurofilament light chain levels ready for routine clinical use? - Yes.

Sofia Sandgren, Maximilian Einsiedler, Pascal Benkert

|Dec 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Eline A J Willemse, Sofia Sandgren, Pascal Benkert

|Nov 05, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert

|Aug 04, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.

Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren

Pageof 2